Case report: Efgartigimod treatment in two pediatric patients with chronic inflammatory demyelinating polyneuropathy
This is the first report of efgartigimod use in pediatric patients with CIDP. Efgartigimod was generally well tolerated, and some clinical improvements were observed in this population. However, given the small sample size, these findings should be considered preliminary and require confirmation in larger, prospective studies.
Authors
- Chi Hou (ORCID: https://orcid.org/0000-0002-1505-6918)
- Yuanyuan Gao (ORCID: https://orcid.org/0000-0001-6186-5436)
- Yanping Ran
- Xiaolan Mo
- Zongzong Chen
- Wenlin Wu
- Wenxiao Wu
- Xuexia Ma
- Haixia Zhu
- Xiaojing Li
Institutions
- Guangzhou Women and Children Medical Center (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-12
- DOI
- https://doi.org/10.3389/fimmu.2025.1741057
- Citations
- 1
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 39.15